Incidence Rates of Interstitial Lung Disease Events in Tofacitinib-Treated Rheumatoid Arthritis Patients: Post Hoc Analysis From 21 Clinical Trials.
J Clin Rheumatol
; 27(8): e482-e490, 2021 Dec 01.
Article
in En
| MEDLINE
| ID: mdl-32826657
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Arthritis, Rheumatoid
/
Lung Diseases, Interstitial
/
Antirheumatic Agents
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Incidence_studies
/
Prognostic_studies
Limits:
Aged
/
Humans
Language:
En
Journal:
J Clin Rheumatol
Journal subject:
FISIOLOGIA
/
ORTOPEDIA
/
REUMATOLOGIA
Year:
2021
Type:
Article